𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclin D1 overexpression associates with radiosensitivity in oral squamous cell carcinoma

✍ Scribed by Satoru Shintani; Mariko Mihara; Yoshiya Ueyama; Tomohiro Matsumura; David T.W. Wong


Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
344 KB
Volume
96
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Overexpression of cyclin D1, a G1 cell cycle regulator, is often found in many different tumor types, including oral squamous cell carcinomas (SCC). Recent laboratory experiments have demonstrated that cyclin D1 levels can influence radiosensitivity in various cell lines. This study evaluated the relationship between cyclin D1 expression levels and radiosensitivity in nine oral SCC cell lines (HSC2, HSC3, HSC4, SCC15, SCC25, SCC66, SCC111, Ca9‐22, and NAN2) and 41 clinical patients with oral SCC who underwent preoperative radiation therapy. Radiosensitivity of the nine oral SCC cell lines differed greatly in their response to radiation, assessed by a standard colony formation assay. Likewise, the expression of cyclin D1 varied, and the magnitude of the cyclin D1 expression correlated with increased tumor radiosensitivity. The similar significant association between the response to preoperative radiation therapy and cyclin D1 overexpression was observed in the oral SCC patients who were treated with preoperative radiation therapy. These results suggest that cyclin D1 expression levels correlate to radiosensitivity and could be used to predict the effectiveness of radiation therapy on oral SCC. © 2001 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Inhibition of cyclin D1 expression by cy
✍ Xiaojian Zhou; Zhiyuan Zhang; Xiao Yang; Wantao Chen; Ping Zhang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 431 KB 👁 2 views

## Abstract Cyclin D1 is a well‐known cell cycle regulator. Recently, its pro‐survival function has been revealed in several tumors. Because increasing expression of cyclin D1 is a common event in oral squamous cell carcinoma (OSCC) and has been correlated with cisplatin resistance, we investigated

Overexpression of cyclin D2 is associate
✍ Shao Chen Liu; Daniel E. Bassi; Shi Yu Zhang; Dana Holoran; Claudio J. Conti; An 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Overexpression of cyclin D2 was studied in 10 human squamous cell carcinoma lines, to establish whether this gene plays a role in tumor progression. We found that those cell lines that overexpressed cyclin D2 (CCND2) had the most invasive in vivo behavior. The invasive ability of the cell lines was

Amplification of cyclin D1 in squamous c
✍ Jan A. Åkervall; Rob J. A. M. Michalides; Hiroyuki Mineta; Alfons Balm; Åke Borg 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

## Background: Abnormalities of chromosome band 11q13 are frequent in squamous cell carcinoma of the head and neck (scchn). the oncogene ccnd1 is located at 11q13 and encodes cyclin d1, a cell cycle-regulating protein. the authors investigated the clinical relevance and associations between amplifi

Cyclin D1 overexpression as a prognostic
✍ Shigenao Nagasawa; Masahiko Onda; Koji Sasajima; Hiroshi Makino; Kiyohiko Yamash 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

## Abstract ## Background and Objectives Cyclin D1 is known to play important roles in the G1/S check‐point of the cell cycle. We investigated the correlation between cyclin D1 overexpression and clinical characteristics to clarify its prognostic significance in patients with esophageal cancer. #

Molecular alterations associated with cy
✍ Gema Moreno-Bueno; Sandra Rodríguez-Perales; Carolina Sánchez-Estévez; Raquel Ma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB 👁 1 views

## Abstract __Cyclin D1__ is frequently overexpressed in human neoplasias by gene rearrangement and amplification. In addition, Ras, PTEN and β‐catenin appear to modulate cyclin D1 levels. Since the causes of cyclin D1 overexpression are poorly understood in EC, we investigated whether or not this

EGFR protein overexpression and mutation
✍ Shiang-Fu Huang; Wen-Yu Chuang; I-How Chen; Chun-Ta Liao; Hung-Ming Wang; Ling-L 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

## Abstract ## __Background.__ Epidermal growth factor receptor (EGFR)‐targeted therapy has been extensively assessed in human cancer treatment. We appraised the possible role of tyrosine kinase inhibitors (TKIs) in areca quid (AQ)‐associated oral cavity squamous cell carcinomas (OSCCs) by examini